Moderna’s COVID-19 Vaccine Triggers Immune Response

July 20, 2020

Moderna’s COVID-19 Vaccine Triggers Immune Response

Moderna has released initial results from its first in human trial of a coronavirus vaccine, which prompted an immune response in all 45 volunteers to receive it. The company has plans to begin a larger phase III clinical trial, which will test 30,000 people, with half receiving a placebo, beginning July 27. This trial is expected to be completed in October. Yourway has the capacity to provide clinical supplies, storage, and transportation for large-scale trials around the world.

Back to Index

Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Schedule a Meeting

Media

Articles

The New Normal in Clinical Trial Protection

Open chat

Hello! How can I help you?